Stockreport

Nucleic Acid Therapeutics CDMO Market Research Report 2024-2034 Featuring Strategic Analysis of Lonza Group, Catalent, and Thermo Fisher Scientific Among Others [Yahoo! Finance]

Catalent, Inc.  (CTLT) 
Last catalent, inc. earnings: 2/3 07:30 am Check Earnings Report
US:NYSE Investor Relations: investor.catalent.com
PDF The global nucleic acid therapeutics CDMO market accounted for USD 12.13 billion in 2023 and is expected to reach USD 32.78 billion by 2034 with a CAGR of 9.46% during [Read more]